妥洛特罗贴剂联合激素吸入治疗婴幼儿喘息性疾病的临床观察  

Clinical Observation of Tulobuterol Patch Combined With Inhaled Corticosteroid in the Treatment of Infantile Asthmatic Disease

作　　者：李鹏程[1] 梁洁竞[1] 张磊[1] 

机构地区：[1]黑龙江省医院儿科,黑龙江哈尔滨150036

出　　处：《中国继续医学教育》2016年第21期151-153,共3页China Continuing Medical Education

摘　　要：目的探讨妥洛特罗贴剂联合雾化吸入治疗婴幼儿喘息性疾病的临床有效性和不良反应。方法将100例轻中度婴幼儿喘息性疾病患儿随机分为治疗组和对照组。治疗组50例,对照组50例,两组均给予雾化吸入布地奈德混悬液1.0 ml/次及复方异丙托溴铵0.8 ml/次,2次/d,并给予止咳化痰对症处理,合并感染者使用抗生素;治疗组加用妥洛特罗贴剂0.5 mg,睡前1贴。比较两组呼吸道症状消失时间。结果治疗组治疗效果优于对照组,两组治疗效果对比,差异具有统计学意义(P<0.05)。结论妥洛特罗贴剂联合雾化吸入治疗婴幼儿喘息性疾病安全可靠,疗效显著。Objective To observe the clinical efifcacy and adverse reactions of tulobuterol patch combined with inhalation therapy of wheezing infants with mild to moderate disease. Methods 100 cases of patients with mild to moderate infant wheezing disease were randomly divided into treatment group and control group. With 50 cases of treatment group and 50 cases of control group, two groups were given by inhalation budesonide 1.0 ml/times and compound ammonium bromide 0.8 ml/time, 2 times/d, and given by symptomatic treatment of cough and phlegm and co-infection with antibiotics;Treatment group were given by tulobuterol patch 0.5 mg before going to bed. Disappeared time of respiratory symptoms were compared. Results The effect of treatment group was better than the control group, the difference was statistically signiifcant, P〈0.05. Conclusion Tulobuterol patch inhalation therapy combined with mild to moderate asthmatic disease in infants is safe and reliable and has a signiifcant effect.

关 键 词：婴幼儿喘息 妥洛特罗贴剂 雾化吸入 

分 类 号：R725[医药卫生—儿科]